Search Results - "Akamatsu, Hayato"

Effects of changing the timing of warfarin administration in combination with fluconazole on prolongation of the PT-INR: a case report by Akamatsu, Hayato, Nakagawa, Hiroo, Matsumaru, Ichiro, Hashizume, Junya, Harasawa, Hitomi, Kodama, Yukinobu, Miura, Takashi, Ohyama, Kaname

“…Fluconazole (FLCZ) inhibits cytochrome P450 (CYP) 2C9, 2C19, and 3A4 and has a drug-drug interaction that potentiates the effects of warfarin and prolong the…”
Get full text

Effect of rifampicin administration on CYP induction in a dermatomyositis patient with vasospastic angina attributable to nilmatrelvir/ritonavir-induced blood tacrolimus elevation: A case report by Akamatsu, Hayato, Kohno, Yusuke, Hashizume, Junya, Nakagawa, Hiroo, Kodama, Yukinobu, Kawano, Hiroaki, Maemura, Koji, Ohyama, Kaname

“…Ritonavir (RTV), which is used in combination with nilmatrelvir (NMV) to treat coronavirus disease 2019 (COVID-19), inhibits cytochrome P450 (CYP) 3A, thereby…”
Get full text

Differences in the Adverse Event Profiles of Sodium-Glucose Cotransporter 2 Inhibitors used in Patients with Diabetes Mellitus and Heart Failure: An Analysis Using the Japanese Adverse Drug Event Report Database by Sakamoto, Toshiaki, Miyamoto, Hirotaka, Hashizume, Junya, Akamatsu, Hayato, Akagi, Tomoaki, Kodama, Yukinobu, Hamano, Hirofumi, Zamami, Yoshito, Ohyama, Kaname

“…Background and Objectives Sodium-glucose cotransporter 2 inhibitors (SGLT2i) have recently become a standard treatment for heart failure and renal failure. The…”
Get full text